Press release
High-Grade Glioma Market is expected to reach USD 9.92 billion by 2034
High-Grade Glioma
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70861
The next decade will see accelerated research in precision oncology, immunotherapy, tumor-treating fields (TTF) technology, and next-generation imaging, aiming to improve survival rates and patient quality of life. Increased clinical trial activity and advancements in molecular diagnostics will be critical growth drivers.
Market Overview
• Market Size (2024): USD 5.28 billion
• Forecasted Market Size (2034): USD 9.92 billion
• CAGR (2024-2034): ~6.5%
• Key Drivers: Advances in molecular profiling, increased R&D for targeted therapies, and improved surgical and radiotherapy techniques.
• Challenges: High recurrence rates, limited drug penetration across the blood-brain barrier (BBB), and treatment resistance.
• Leading Players: F. Hoffmann-La Roche Ltd., Novocure Ltd., Merck & Co., Bristol Myers Squibb, Pfizer Inc., Amgen Inc., and Denovo Biopharma.
Segmentation Analysis
By Tumor Type
• Anaplastic Astrocytoma (Grade III)
• Anaplastic Oligodendroglioma (Grade III)
• Glioblastoma Multiforme (Grade IV)
By Treatment Type
• Surgery
• Radiation Therapy
• Chemotherapy (Temozolomide, Carmustine)
• Targeted Therapy (VEGF inhibitors, EGFR inhibitors)
• Immunotherapy (PD-1/PD-L1 inhibitors, CAR-T therapy)
• Tumor Treating Fields (TTF)
By End Use
• Hospitals & Cancer Centers
• Specialty Clinics
• Academic & Research Institutes
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Segmentation Summary
While surgery and chemoradiation remain the standard, targeted therapies, immuno-oncology agents, and TTF devices are increasingly incorporated into treatment protocols for recurrent and advanced HGG.
Explore Full Report here: https://exactitudeconsultancy.com/reports/70861/high-grade-glioma-market
Regional Analysis
North America
• Holds ~46% of market share in 2024.
• Strong adoption of TTF devices and targeted therapies.
• Robust clinical trial ecosystem.
Europe
• EMA-approved innovative therapies driving adoption in major markets like Germany, France, and the UK.
Asia-Pacific
• Fastest-growing region (CAGR > 8%).
• Increasing healthcare investment in China, Japan, and South Korea.
• Expansion of neurosurgical facilities.
Middle East & Africa
• GCC countries leading with improved access to neuro-oncology treatments.
Latin America
• Brazil and Argentina expanding specialized cancer centers.
Regional Summary
North America dominates the market due to advanced healthcare infrastructure, but Asia-Pacific will experience the highest growth due to rising diagnosis rates and healthcare modernization.
Market Dynamics
Key Growth Drivers
1. Rising incidence of brain tumors in aging populations.
2. Precision medicine adoption with genetic and molecular profiling.
3. Regulatory incentives for orphan drug development.
4. Integration of TTF technology into treatment protocols.
Key Challenges
1. High relapse rates despite aggressive treatment.
2. Limited BBB-penetrating therapies.
3. High treatment costs impacting accessibility in developing nations.
4. Neurocognitive side effects from prolonged therapy.
Latest Trends
• Liquid biopsy research for early relapse detection.
• Combination therapy trials (immunotherapy + radiotherapy).
• AI-assisted neuroimaging for early diagnosis.
• Development of next-gen TTF devices for better compliance.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70861
Competitor Analysis
Major Players
• F. Hoffmann-La Roche Ltd. (Avastin® - Bevacizumab)
• Novocure Ltd. (Optune® - Tumor Treating Fields)
• Merck & Co., Inc. (Keytruda® - Pembrolizumab)
• Bristol Myers Squibb (Opdivo® - Nivolumab)
• Pfizer Inc.
• Amgen Inc.
• Denovo Biopharma
• Kintara Therapeutics, Inc.
• Celldex Therapeutics
• ImmunoCellular Therapeutics Ltd.
• DNAtrix Inc.
• Tocagen Inc.
• VBL Therapeutics
• Ziopharm Oncology, Inc.
Competitive Summary
The HGG market is highly research-focused, with companies pursuing BBB-penetrating drugs, combination regimens, and device-based therapies to extend survival.
Conclusion
The high-grade glioma market is poised for transformational growth as precision oncology, immunotherapy, and device-based interventions converge. By 2034, innovations in drug delivery, imaging, and tumor biology understanding will redefine patient outcomes.
Key opportunities include:
• Developing next-gen targeted agents with improved BBB penetration.
• Scaling access to TTF devices in emerging markets.
• Integrating AI-powered imaging for early detection and personalized treatment.
This report is also available in the following languages : Japanese (高悪性度神経膠腫市場), Korean (고등급 신경교종 시장), Chinese (高级别胶质瘤市场), French (Marché du gliome de haut grade), German (Markt für hochgradige Gliome), and Italian (Mercato del glioma di alto grado), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/70861/high-grade-glioma-market#request-a-sample
Our More Reports:
Frontotemporal Dementia Market
https://exactitudeconsultancy.com/reports/70788/frontotemporal-dementia-market
Anesthetic Effect Market
https://exactitudeconsultancy.com/reports/70790/anesthetic-effect-market
Chronic Neuropathic Pain Market
https://exactitudeconsultancy.com/reports/70792/chronic-neuropathic-pain-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release High-Grade Glioma Market is expected to reach USD 9.92 billion by 2034 here
News-ID: 4143990 • Views: …
More Releases from Exactitude Consultancy
Vacuum Insulated Pipe Market Projected to Reach USD 2.36 Billion by 2034
Introduction: A Market Built on Cryogenic Efficiency and Innovation
The global Vacuum Insulated Pipe (VIP) market is witnessing a steady surge driven by the expanding cryogenic industry, increased liquefied natural gas (LNG) trade, and rising demand for efficient liquid gas transportation systems. These specialized double-wall pipes, engineered with high vacuum insulation between inner and outer layers, have become indispensable in industries handling cryogenic fluids such as liquid nitrogen, oxygen, argon, and…
Solar PV Mounting Systems Market is Expected to Reach USD 31.7 Billion by 2034
Introduction: Powering the Next Decade of Solar Expansion
The Solar PV Mounting Systems Market is emerging as a crucial pillar in the clean energy revolution, enabling efficient, cost-effective, and durable installations of photovoltaic (PV) modules across rooftops, open fields, and floating structures. As the world accelerates toward carbon neutrality, the demand for robust, modular, and adaptable mounting systems has intensified across residential, commercial, and utility-scale solar projects.
Download Full PDF Sample Copy…
Tall Oil Fatty Acid Market projected to reach USD 2.21 billion by 2034
Introduction: A Sustainable Feedstock Powering the Future of Bio-based Chemicals
The Tall Oil Fatty Acid (TOFA) Market is gaining strong traction as industries increasingly shift toward renewable, sustainable, and bio-based chemical alternatives. Derived as a byproduct from the kraft pulping process of pine wood, TOFA has become a vital raw material in the production of alkyd resins, dimer acids, lubricants, coatings, and adhesives. Its unique composition-rich in oleic and linoleic acids-makes…
Lithium-Ion Battery Recycling Market Projected to Reach USD 27.3 Billion by 2034
Introduction: Powering the Circular Energy Transition
As the world accelerates toward electrification and clean energy, the demand for lithium-ion batteries has skyrocketed-fueling everything from electric vehicles (EVs) to smartphones and grid storage systems. However, this exponential growth brings with it an urgent environmental challenge: how to sustainably manage end-of-life batteries.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/25354
The Lithium-Ion Battery Recycling Market has emerged as a cornerstone of the global…
More Releases for TTF
High-Grade Glioma (HGG) Clinical Market to Reach $5.6 Billion by 2034, Growing a …
Introduction
High-Grade Gliomas (HGGs) are among the most aggressive and fatal forms of brain cancer, primarily comprising glioblastoma multiforme (GBM) and anaplastic astrocytoma. Despite decades of research, treatment remains challenging due to the tumor's infiltrative nature, blood-brain barrier (BBB) limitations, and resistance to conventional therapies. However, recent breakthroughs in immunotherapy, molecular diagnostics, and gene-based precision medicine are reshaping the treatment landscape.
According to Exactitude Consultancy, the Global High-Grade Glioma (HGG) Clinical Market…
Glioma market is projected to reach USD 7.8 billion by 2034
Gliomas are a diverse group of brain tumors arising from glial cells, which support and protect neurons. They represent the most common type of malignant primary brain tumors, with subtypes ranging from low-grade gliomas (slow-growing) to aggressive forms such as glioblastoma multiforme (GBM). Despite decades of research, gliomas remain difficult to treat due to their invasive nature, resistance to therapies, and limited drug delivery across the blood-brain barrier.
Download Full PDF…
Recurrent Malignant Glioma Market Expected to Hit USD 4.0 Billion by 2034
Gliomas are the most common malignant brain tumors, arising from glial cells in the central nervous system. While initial treatment usually involves surgery, radiotherapy, and chemotherapy, recurrence is frequent, and outcomes remain poor. Recurrent malignant gliomas (rMG), including glioblastomas and anaplastic astrocytomas, represent one of the most challenging areas in oncology, with limited treatment options and median survival often less than a year.
Download Full PDF Sample Copy of Market Report…
TTF Mumbai 2025 Wraps Up on a High Note, Rekindling Travel Trade Momentum in the …
Mumbai, 19th August - The much-anticipated, exclusively B2B TTF Mumbai 2025 concluded today, marking a strong return of India's leading travel trade show to the country's financial capital. Held from 11 to 13 August at the Jio World Convention Centre (JWCC), the event brought together over 9,000 travel trade professionals and 500+ exhibitors, reaffirming Mumbai's role as a vital hub in India's travel ecosystem. With the Diwali travel season approaching,…
Glioblastoma Multiforme Market to Reach USD 6.91 Billion by 2034
Glioblastoma multiforme (GBM) is the most aggressive and common form of primary brain tumor in adults, accounting for nearly 50% of malignant brain tumors. Despite advances in surgery, radiotherapy, and chemotherapy, median survival remains just 12-18 months due to tumor heterogeneity, rapid progression, and high recurrence rates.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70857
The next decade is expected to see significant changes in GBM treatment strategies, with novel…
Drone Motors Market 2019 Future Technological Advancement and Phenomenal Growth …
Drone Motors Market is a detailed research study that provides answers and pertinent questions with respect to the emerging trends and growth opportunities in this industry. It helps identify each of the prominent barriers to growth, apart from identifying the trends within various application segments of the Global market for Drone Motors. Collecting historical and recent data from various authentic resources and depending on all the factors and trends, the…
